Making inferences with incomplete epidemiological data: a proof-of-concept estimating measles vaccine coverage across Canada
- 1University of Colorado Boulder
Abstract
Background & aims of studyCurrent measles outbreaks around the world have highlighted the evolving immunity landscape of some vaccine-preventable diseases (VPDs). In Canada, there have been approximately 1,100 reported measles cases between January and June 2026 alone. This far exceeds the previous average annual case counts of <200. This significant outbreak has underscored the need to better understand the present state of population immunity to measles in Canada, an essential input parameter for outbreak response models. Most population immunity in this setting is derived from routine childhood vaccination, but vaccine coverage data is available heterogeneously across the country and is typically collected cross-sectionally to monitor population adherence to immunization schedules rather than to inform population-level susceptibility. This study developed statistical methods to adapt available measles vaccine coverage estimates into more complete estimates of present-day immunity in Canada by age and province/territory (PT).
Methods & resultsFirst, a standardized dataset for vaccine coverage by PT was collated from existing publicly-available datasets and reports. A significant number of vaccine coverage estimates were missing by PT, dose, and year. We used Gaussian Process models to impute current coverage with at least one dose of a measles vaccine, to create a complete modelled dataset by PT and age. Our modelling framework was tested against data for England, which was much more complete, to validate our approach.
ImplicationsWe developed methodology for estimating vaccine coverage in the absence of detailed population immunity data, to support ongoing measles outbreak modelling response work. While this project focused on measles, we built the associated code/tools such that the methodology can be applied to other vaccine-preventable diseases in future outbreak settings.
HighlightsO_LIUsing statistical modelling, we estimated current measles vaccine coverage in Canada. C_LIO_LIWe developed a flexible Gaussian Process model as a proof of concept. C_LIO_LIRegions were related using socioeconomic and vaccine hesitancy indicators. C_LI
Related
- Optimizing motor functions in incomplete spinal cord injury with simultaneous application of transcranial direct current stimulation and virtual reality assisted treadmill training: a study protocol for a randomized controlled trial {1a}
- Cardiometabolic stress induces atrial myopathy in mice, characterized by structural remodelling, metabolic dysfunction, and incomplete transcriptional recovery.
- Contralateral atypical femoral fracture following a single dose of denosumab after incomplete teriparatide therapy in a patient with long-term bisphosphonate exposure: A case report
- Thyroid eye disease with dysthyroid optic neuropathy 15 years after incomplete thyroidectomy
- Incomplete Uterine Artery Embolization Secondary to Collateral Parasitization from Celiac and Superior Mesenteric Arterial Branches: A Case Report and Literature Review.
BibTeX
@misc{hadley2026making,
title = {{Making inferences with incomplete epidemiological data: a proof-of-concept estimating measles vaccine coverage across Canada}},
author = {L. Hadley and R. Milwid and V. Hongoh and R. Wasfi and S. M. Kissler and I. Papst},
howpublished = {medRxiv},
year = {2026},
month = jul,
doi = {10.64898/2026.07.16.26358151},
url = {https://www.medrxiv.org/content/10.64898/2026.07.16.26358151v2},
note = {CC BY-ND},
}
RIS
TY - UNPB
TI - Making inferences with incomplete epidemiological data: a proof-of-concept estimating measles vaccine coverage across Canada
AU - L. Hadley
AU - R. Milwid
AU - V. Hongoh
AU - R. Wasfi
AU - S. M. Kissler
AU - I. Papst
PY - 2026
DA - 2026/07/16
PB - medRxiv
DO - 10.64898/2026.07.16.26358151
UR - https://www.medrxiv.org/content/10.64898/2026.07.16.26358151v2
AB - Background & aims of studyCurrent measles outbreaks around the world have highlighted the evolving immunity landscape of some vaccine-preventable diseases (VPDs). In Canada, there have been approximately 1,100 reported measles cases between January and June 2026 alone. This far exceeds the previous average annual case counts of <200. This significant outbreak has underscored the need to better understand the present state of population immunity to measles in Canada, an essential input parameter for outbreak response models. Most population immunity in this setting is derived from routine childhood vaccination, but vaccine coverage data is available heterogeneously across the country and is typically collected cross-sectionally to monitor population adherence to immunization schedules rather than to inform population-level susceptibility. This study developed statistical methods to adapt available measles vaccine coverage estimates into more complete estimates of present-day immunity in Canada by age and province/territory (PT). Methods & resultsFirst, a standardized dataset for vaccine coverage by PT was collated from existing publicly-available datasets and reports. A significant number of vaccine coverage estimates were missing by PT, dose, and year. We used Gaussian Process models to impute current coverage with at least one dose of a measles vaccine, to create a complete modelled dataset by PT and age. Our modelling framework was tested against data for England, which was much more complete, to validate our approach. ImplicationsWe developed methodology for estimating vaccine coverage in the absence of detailed population immunity data, to support ongoing measles outbreak modelling response work. While this project focused on measles, we built the associated code/tools such that the methodology can be applied to other vaccine-preventable diseases in future outbreak settings. HighlightsO_LIUsing statistical modelling, we estimated current measles vaccine coverage in Canada. C_LIO_LIWe developed a flexible Gaussian Process model as a proof of concept. C_LIO_LIRegions were related using socioeconomic and vaccine hesitancy indicators. C_LI
ER -